318 related articles for article (PubMed ID: 28477013)
1. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
[TBL] [Abstract][Full Text] [Related]
2. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
[TBL] [Abstract][Full Text] [Related]
3. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.
Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA
Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
5. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.
Gallo M; De Luca A; Lamura L; Normanno N
Ann Oncol; 2012 Mar; 23(3):597-604. PubMed ID: 21551002
[TBL] [Abstract][Full Text] [Related]
8. Role of biphasic calcium phosphate ceramic-mediated secretion of signaling molecules by macrophages in migration and osteoblastic differentiation of MSCs.
Wang J; Liu D; Guo B; Yang X; Chen X; Zhu X; Fan Y; Zhang X
Acta Biomater; 2017 Mar; 51():447-460. PubMed ID: 28126596
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.
Schiraldi C; Zappavigna S; D' Agostino A; Porto S; Gaito O; Lusa S; Lamberti M; De Rosa M; De Rosa G; Caraglia M
Cancer Biol Ther; 2014; 15(11):1524-32. PubMed ID: 25482949
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.
Kopecka J; Porto S; Lusa S; Gazzano E; Salzano G; Pinzòn-Daza ML; Giordano A; Desiderio V; Ghigo D; De Rosa G; Caraglia M; Riganti C
Oncotarget; 2016 Apr; 7(15):20753-72. PubMed ID: 26980746
[TBL] [Abstract][Full Text] [Related]
13. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
14. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
Brennen WN; Kisteman LN; Isaacs JT
Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.
Li W; Zhou Y; Yang J; Zhang X; Zhang H; Zhang T; Zhao S; Zheng P; Huo J; Wu H
J Exp Clin Cancer Res; 2015 May; 34(1):52. PubMed ID: 25986392
[TBL] [Abstract][Full Text] [Related]
16. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3/CCR7 activation.
Huang X; Su K; Zhou L; Shen G; Dong Q; Lou Y; Zheng S
J Cell Biochem; 2013 Dec; 114(12):2834-41. PubMed ID: 23939705
[TBL] [Abstract][Full Text] [Related]
20. Cytokine interactions in mesenchymal stem cells from cord blood.
Liu CH; Hwang SM
Cytokine; 2005 Dec; 32(6):270-9. PubMed ID: 16377203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]